Page last updated: 2024-09-04

vatalanib and Osteolysis

vatalanib has been researched along with Osteolysis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bachelier, R; Clézardin, P; Confavreux, CB; Croset, M; Goehrig, D; Peyruchaud, O; van der Pluijm, G1

Other Studies

1 other study(ies) available for vatalanib and Osteolysis

ArticleYear
Combination of anti-angiogenic therapies reduces osteolysis and tumor burden in experimental breast cancer bone metastasis.
    International journal of cancer, 2014, Sep-15, Volume: 135, Issue:6

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Breast Neoplasms; Female; Human Umbilical Vein Endothelial Cells; Humans; Immunocompromised Host; Mice; Mice, Inbred C3H; Osteolysis; Phthalazines; Pregnancy; Pyridines; Receptors, Vascular Endothelial Growth Factor; RNA, Small Interfering; Transfection; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2014